- Eli Lilly, Novo Nordisk’s Historic GLP-1 Pricing Deals – What Investors Need To Know Seeking Alpha
- U.S. deal could cut costs for popular weight-loss drugs. What’s that mean for Canada? CBC
- Trump’s Ozempic Deal Has a Major Flaw The Atlantic
- Novo Nordisk shares fall after Trump deal to slash obesity drug prices CTV News
- Trump’s weight loss drug deal promises big savings — but some details are murky NBC News
Add Comment